Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of EPA and DHA Supplementation in Systemic Lupus Erythematosus and Primary Antiphospholipid Syndrome

NCT01956188 is registered in ClinicalTrials.gov with University of Sao Paulo as lead sponsor.

NCT NCT01956188
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01956188 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of EPA and DHA Supplementation in Systemic Lupus Erythematosus and Primary Antiphospholipid Syndrome
Lead sponsor
University of Sao Paulo
Phase
Not applicable
Overall status
Unknown status
Start date
May 31, 2014
Completion date
December 31, 2017
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary antiphospholipid syndrome, systemic lupus erythematosus